Montpellier, France

Philippe Pasero

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Philippe Pasero in Cancer Treatment

Introduction

Philippe Pasero is a notable inventor based in Montpellier, France. He has made significant contributions to the field of cancer treatment, particularly in the area of diffuse large B-cell lymphoma. His innovative methods aim to improve patient outcomes through personalized medicine.

Latest Patents

Philippe Pasero holds a patent for a method that predicts a patient's response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma. This invention involves several steps, including determining the expression levels of specific genes in a biological sample from the patient. By comparing these levels to predetermined reference values, the method calculates a DNA repair score. This score helps in concluding whether a patient is likely to respond to treatment, thereby guiding therapeutic decisions.

Career Highlights

Throughout his career, Philippe Pasero has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Montpellier. His work has focused on advancing the understanding of cancer biology and improving treatment strategies.

Collaborations

Philippe has collaborated with notable colleagues, including Jerome Moreaux and Guillaume Cartron. These partnerships have contributed to the development of innovative approaches in cancer research and treatment.

Conclusion

Philippe Pasero's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patented methods offer hope for improved patient care and personalized treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…